Fisetin and Fisetin for Senolytic / healthspan (humans)
Each entry’s own grades, side by side. A grade says how strong the evidence is for one outcome — it does not rank one entry over the other.
Compound or practice
Fisetin
A flavonoid senolytic star in mice with essentially no completed human outcome data — trials are ongoing.
Grade D1 graded outcomerevised Jul 10, 2026
A structured monograph in Prometheus's bundled library. Its grades are the monograph's own reading of the evidence, not a peer-reviewed review.
Evidence brief
Fisetin for Senolytic / healthspan (humans)
Evidence grade D — No completed human outcomes
Grade D1 graded outcomerevised Jul 10, 2026
Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.
Graded in both
Outcomes are matched by name. Two entries can describe the same outcome in different words, so one listed further down may still be graded in the other.
| Outcome | Fisetin | Fisetin for Senolytic / healthspan (humans) |
|---|---|---|
| Senolytic / healthspan (humans) | Evidence grade DUnclear effectlowNo completed human outcomes | Evidence grade DUnclear effectlowNo completed human outcomes |
Graded only in Fisetin
None — every outcome it grades is graded in both.
Graded only in Fisetin for Senolytic / healthspan (humans)
None — every outcome it grades is graded in both.
What each entry says about the other
- Fisetin for Senolytic / healthspan (humans)’s entry · Goes with: Read the full Fisetin monograph
Both columns are read from the entries as they stand in this library. A comparison is not advice to take either one, and it is no substitute for a clinician who knows the person.